If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Overview

Mutsa is a Research Fellow at Macquarie University Centre for the Health Economy (MUCHE).  Her research interests include drug and non-drug technology assessments, program evaluation, systematic reviews and public health.

Prior to joining MUCHE she was a Research Associate at Curtin University in the Department of Epidemiology and Biostatistics and co-ordinator of the Cancer Council (Western Australia) Cancer Epidemiology Network. She has also worked as a Research Assistant at the WHO Collaborating Centre for Obesity Prevention at Deakin University and the Department of Epidemiology and Preventive Medicine at Monash University in Melbourne, a public health research analyst at National Health Services in the United Kingdom, and as an Associate Consultant for a pharmaceutical consulting company in the United Arab of Emirates. 

Since joining MUCHE, Mutsa reviews and conducts evaluations for the Pharmaceutical Benefit Advisory Committee (PBAC). Mutsa assists in teaching the short courses on economic evaluation and the health economics unit of the Masters of Public Health. She also works on a number of commissioned projects and is currently an executive member of the Australian Health Economics Society as the public officer (since 2017).

Mutsa has published peer-reviewed journal articles, and presented at national and international conferences. 

 

Education/Academic qualification

Public Health, PhD, Monash University

4 Mar 201310 May 2016

Health Economics, Masters of Public Health, The University of Melbourne

13 Feb 20071 Dec 2008

Biomedical Science, Bachelor of Science, Deakin University

16 Feb 200418 Dec 2006

Fingerprint Dive into the research topics where Mutsa Gumbie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Zimbabwe Medicine & Life Sciences
Cost-Benefit Analysis Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Tryptamines Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Quality-Adjusted Life Years Medicine & Life Sciences
Oral Contraceptives Medicine & Life Sciences
Pharmacists Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2018

Research Outputs 2014 2019

  • 100 Citations
  • 4 h-Index
  • 8 Article
  • 6 Meeting abstract
  • 2 Review article

Cost-effectiveness of reclassifying triptans in Australia: Application of an economic evaluation approach to regulatory decisions

Parkinson, B., Gumbie, M., Cutler, H., Gauld, N., Mumford, V. & Haywood, P., Mar 2019, In : Value in Health. 22, 3, p. 293-302 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Tryptamines
Cost-Benefit Analysis
Migraine Disorders
Pharmacists
Headache Disorders
Oral Contraceptives
Pharmacists
Cost-Benefit Analysis
Prescriptions
Costs and Cost Analysis

Over-the-counter contraceptive pill could save the health system $96 million a year

Parkinson, B. & Gumbie, M., 30 May 2019, The Conversation.

Research output: Contribution to Newspaper/Magazine/WebsiteArticleResearch

Open Access
File

Cost-effectiveness of down scheduling triptans in Australia

Parkinson, B., Gumbie, M. & Cutler, H., Sep 2018, In : Value in Health. 21, Suppl. 2, p. S94 1 p., PND16.

Research output: Contribution to journalMeeting abstractResearch

Tryptamines
Cost-Benefit Analysis
Migraine Disorders
Headache Disorders
Costs and Cost Analysis

Cost-effectiveness of screening a 5 year old child for hearing loss using Sound Scouts compared with no screening: a decision model analysis

Gumbie, M., Parkinson, B., Bowman, R., Song, R. & Cutler, H., Sep 2018, In : Value in Health. 21, Suppl. 2, p. S70 1 p., PMD17.

Research output: Contribution to journalMeeting abstractResearch

Decision Support Techniques
Hearing Loss
Cost-Benefit Analysis
Quality-Adjusted Life Years
Costs and Cost Analysis